AGC Biologics today announced it is partnering with Repair Biotechnologies to tackle one of the world's most persistent health challenges and cause of mortality. The collaboration will focus on ...

Biotechnology company Moderna (NASDAQ:MRNA) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 45.4% ...

Q3 earnings beat estimates but pipeline setback and lower 2025 guidance raise concerns. Full analysis of results and outlook.

Moderna (MRNA) stock is in focus as the company completes U.S. mRNA production network, investing $140M in Massachusetts and ...

AGC Biologics is partnering with Repair Biotechnologies to develop and manufacture a novel mRNA therapy to rapidly stabilize ...

As the earnings season comes to an end, the focus is back on pipeline updates from biotech players. While the bigwigs did not come out with much updates, pipeline and regulatory updates took ...

Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in cell-free, enzymatic DNA production, and Spindle Biotech Inc. (“Spindle Biotech”), a company focused on the development of a ...

Moderna beat analysts’ revenue expectations by 10.7% last quarter, reporting revenues of $142 million, down 41.1% year on year. It was a satisfactory quarter for the company, with a beat of analysts’ ...

Telemark Asset Management, LLC established a new position in Moderna ( MRNA +1.10%), acquiring 500,000 shares valued at approximately $12.91 million as of September 30, 2025, according to a November ...

Just over two years ago, Robert Malone was living a relatively quiet life on his Virginia farm, training and breeding Portuguese horses with his wife, Jill. But once the novel coronavirus was ...

When Dr. Anna Blakney interviewed for a position at the University of British Columbia at the start of 2020, mRNA technology—her area of research expertise—wasn’t yet widely known by the general ...